Ascorbic acid 4700 MG / polyethylene glycol 3350 100000 MG / potassium chloride 1015 MG /... — RxCUI 800918
RxNorm drug concept · Semantic branded drug
RxCUI 800918
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI800918
Official nameAscorbic acid 4700 MG / polyethylene glycol 3350 100000 MG / potassium chloride 1015 MG / sodium ascorbate 5900 MG / sodium chloride 2690 MG / sodium sulfate 7500 MG Powder for Oral Solution [MoviPrep]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asvit-C 4700 MG / POLYETHYLENE GLYCOL 3350 100000 MG / K+ Chloride 1015 MG / Sodium Ascorbate 5900 MG / NaCl 2690 MG / sodium sulfate 7500 MG Powder for Oral Solution [MoviPrep]; MoviPrep Powder for Oral Solution; MoviPrep (ascorbic acid 4.7 GM / polyethylene glycol 3350 100 GM / potassium chloride 1.015 GM / sodium ascorbate 5.9 GM / sodium chloride 2.69 GM / sodium sulfate 7.5 GM) Powder for Oral Solution; vit-C 4700 MG / POLYETHYLENE GLYCOL 3350 100000 MG / Pot Chloride 1015 MG / Sodium Ascorbate 5900 MG / NaCl 2690 MG / sodium sulfate 7500 MG Powder for Oral Solution [MoviPrep]; vitamin C 4700 MG / POLYETHYLENE GLYCOL 3350 100000 MG / K+ Chloride 1015 MG / Sodium Ascorbate 5900 MG / NaCl 2690 MG / sodium sulfate 7500 MG Powder for Oral Solution [MoviPrep] +1 more
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,946 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Polyethylene Glycol 3350: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- You can generally expect a bowel movement within 1 to 3 days after taking it. It's not meant to work in an hour like some other laxatives — it works gradually. If you haven't gone...
- How long does it take for Polyethylene Glycol 3350 to work?
- You can stir it into any 4 to 8 ounces of beverage — water, juice, coffee, tea, whatever you like, cold or hot. The key is to stir it well until it's completely dissolved. Don't dr...
- Can I mix it into any drink, or does it have to be water?
🕸️ Concept Web — How Ascorbic acid 4700 MG / polyethylene glycol 3350... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ascorbic acid 4700 MG / polyethylene glycol 3350 100000 MG / potassium chloride 1015 MG / sodium ascorbate 5900 MG / sodium chloride 2690 MG / sodium sulfate 7500 MG Powder for Oral Solution [MoviPrep]
RxCUI 800918 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 7
The active substance itself — no strength, form, or brand attached yet.
-
Ascorbic acid
1151IN -
Polyethylene glycol 3350
221147IN -
Potassium chloride
8591IN -
Sodium ascorbate
267366IN -
Sodium chloride
9863IN -
Sodium sulfate
36721IN -
Ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride / sodium sulfate
1007544MIN
-
Ascorbic acid
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
MoviPrep
669559BN
-
MoviPrep
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride / sodium sulfate Powder for Oral Solution
1870185SCDF -
Ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride / sodium sulfate Oral Powder Product
1870184SCDG -
Ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride / sodium sulfate Oral Product
1152330SCDG -
Ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride / sodium sulfate Powder for Oral Solution [MoviPrep]
1870188SBDF -
MoviPrep Oral Powder Product
1870189SBDG -
MoviPrep Oral Product
1182827SBDG -
Powder for Oral Solution
1540455DF -
Oral Powder Product
1294711DFG - +1 more in this family
-
Ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride / sodium sulfate Powder for Oral Solution
-
Clinical & branded drugs 8
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ascorbic acid 4700 MG / polyethylene glycol 3350 100000 MG / potassium chloride 1015 MG / sodium ascorbate 5900 MG / sodium chloride 2690 MG / sodium sulfate 7500 MG Powder for Oral Solution
800915SCD -
Ascorbic acid 4700 MG
1870178SCDC -
Polyethylene glycol 3350 100000 MG
1870179SCDC -
Potassium chloride 1015 MG
1870180SCDC -
Sodium ascorbate 5900 MG
1870181SCDC -
Sodium chloride 2690 MG
1870182SCDC -
Sodium sulfate 7500 MG
1870183SCDC -
Ascorbic acid 4700 MG / polyethylene glycol 3350 100000 MG / potassium chloride 1015 MG / sodium ascorbate 5900 MG / sodium chloride 2690 MG / sodium sulfate 7500 MG [MoviPrep]
1870187SBDC
-
Ascorbic acid 4700 MG / polyethylene glycol 3350 100000 MG / potassium chloride 1015 MG / sodium ascorbate 5900 MG / sodium chloride 2690 MG / sodium sulfate 7500 MG Powder for Oral Solution
Showing up to 8 concepts per family — 24 of 25 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ascorbic acid 4700 MG / polyethylene glycol 3350 100000 MG / potassium chloride 1015 MG / sodium ascorbate 5900 MG / sodium chloride 2690 MG / sodium sulfate 7500 MG Powder for Oral Solution
SCD · 800915 -
Ascorbic acid 4700 MG
SCDC · 1870178 -
Polyethylene glycol 3350 100000 MG
SCDC · 1870179 -
Potassium chloride 1015 MG
SCDC · 1870180 -
Sodium ascorbate 5900 MG
SCDC · 1870181 -
Sodium chloride 2690 MG
SCDC · 1870182 -
Sodium sulfate 7500 MG
SCDC · 1870183 -
Ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride / sodium sulfate Powder for Oral Solution
SCDF · 1870185 -
Ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride / sodium sulfate Oral Powder Product
SCDG · 1870184 -
Ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride / sodium sulfate Oral Product
SCDG · 1152330
Brand-Name Concepts
-
Ascorbic acid 4700 MG / polyethylene glycol 3350 100000 MG / potassium chloride 1015 MG / sodium ascorbate 5900 MG / sodium chloride 2690 MG / sodium sulfate 7500 MG [MoviPrep]
SBDC · 1870187 -
Ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride / sodium sulfate Powder for Oral Solution [MoviPrep]
SBDF · 1870188 -
MoviPrep Oral Powder Product
SBDG · 1870189 -
MoviPrep Oral Product
SBDG · 1182827 -
MoviPrep
BN · 669559
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 800918 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 65649-0201-75 | 1 KIT in 1 CONTAINER (65649-201-75) * 1 L in 1 POUCH * 1... | MoviPrep | Salix Pharmaceuticals, Inc. | 2006-10-01 |
| 65649-0201-76 | 1 KIT in 1 CONTAINER (65649-201-76) * 1 L in 1 POUCH * 1... | MoviPrep | Salix Pharmaceuticals, Inc. | 2006-10-01 |
Observed labelers:
Salix Pharmaceuticals, Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.